Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $9.5050 (-4.23%) ($9.5050 - $9.5050) on Wed. Feb. 10, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.95% (three month average) | RSI | 58 | Latest Price | $9.5050(-4.23%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.5% a day on average for past five trading days. | Weekly Trend | BCRX advances 3.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(43%) IBB(38%) IWO(37%) IWC(36%) IWM(36%) | Factors Impacting BCRX price | BCRX will decline at least -3.475% in a week (0% probabilities). VIXM(-19%) UUP(-13%) VXX(-8%) IGOV(-4%) TBT(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.475% (StdDev 6.95%) | Hourly BBV | -1.9 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $9.8(-3.01%) | 10 Day Moving Average | $9.9(-3.99%) | 20 Day Moving Average | $9.44(0.69%) | To recent high | -20.1% | To recent low | 88.8% | Market Cap | $1.677b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |